LTTL vs Telos Rx: Pricing, medications, and compounding differences
Quick verdict: LTTL emphasizes full-dose compounded GLP-1 prepared by U.S.A. licensed pharmacies with “up to $140 off your first month” and independent lab verification, while Telos Rx highlights choice between semaglutide and tirzepatide with prices “as low as $99 per month” and a US-licensed provider deciding which molecule is right. This comparison focuses on pricing and discounts, medication options, compounding and regulatory notes, and how each verifies and delivers medication.
See LTTL pricing and start eligibility check
LTTL vs Telos Rx: pricing and first-month offers
Price is a clear early difference. LTTL advertises “up to $140 off your first month” with a code auto-applied and lists example prices like “$249” and “$129” in captured content. Telos Rx lists semaglutide “as low as $99 per month” and tirzepatide “as low as $139 per month,” and explicitly notes “Pay $0 if not approved” in the captured evidence. Both note that pricing is subject to the live offer and eligibility checks.
Check Telos Rx semaglutide and tirzepatide pricing
Medication options and prescribing model
LTTL promotes “Full-dose GLP-1” compounded medications and frames them as helping regulate appetite and promote fullness. Telos Rx offers two molecule choices: “Semaglutide acts on GLP-1” and “Tirzepatide acts on GLP-1 and GIP together,” with a US-licensed provider deciding which is right. Both providers require a clinician determination that treatment is medically appropriate.
Compounding, verification and regulatory notes
Both sources include the regulatory caution that “Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.” LTTL emphasizes that its compounded medications are “Compounded By U.S.A. Licensed Pharmacies,” “prepared in a state-licensed pharmacy,” and “independently verified in FDA registered labs,” with potency “Confirmed every 3–6 months to stay within ± 10 % of the target strength.” Telos Rx also states its semaglutide and tirzepatide are compounded and prescription-only, with US-licensed provider review required.
Fulfillment, delivery and cancellation
LTTL claims medications are “delivered to your door exactly when you need it.” Telos Rx notes “Cancel anytime, no penalties” and that your price depends on your plan. Neither source supplies a full shipping or membership policy beyond these captured lines, and both advise confirming eligibility, state availability, renewal terms and total cost before enrolling.
Five key differences at a glance
| Criteria | LTTL | Telos Rx |
|---|---|---|
| Starting price / offers | “Up to $140 off your first month”; example prices $249, $129 | Semaglutide “as low as $99 per month”; tirzepatide “as low as $139 per month” |
| Medication choices | Full-dose GLP-1 compounded options | Semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP) |
| Compounding and pharmacy | “Compounded By U.S.A. Licensed Pharmacies”; state-licensed pharmacy; independent lab verification | Compounded medications prescribed after US-licensed provider review |
| Regulatory note | “Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.” | Same regulatory note: compounded medications are not FDA-approved |
| Cancellation / pricing flexibility | Captured content does not supply explicit cancel policy; pricing and terms may change | “Cancel anytime, no penalties”; price depends on your plan |
How they present clinical review and approvals
Both LTTL and Telos Rx state that treatment is available only when a licensed clinician determines it is medically appropriate. Telos Rx repeatedly frames the choice of molecule as determined by a “US-licensed provider.” LTTL notes clinician review is required and highlights pharmacy-level verification in addition to clinician oversight.
Review LTTL clinician and pharmacy verification
Choosing between LTTL and Telos Rx
Use the primary keyword when deciding: LTTL vs Telos Rx centers on whether you prioritize pharmacy compounding verification and an advertised first-month discount, or molecule choice and lower listed starting prices. LTTL emphasizes compounded full-dose GLP-1 “prepared in a state-licensed pharmacy” with independent lab checks and an “up to $140 off your first month” offer. Telos Rx emphasizes access to semaglutide “as low as $99 per month” and tirzepatide “as low as $139 per month,” and that a US-licensed provider will match the molecule to you.
Compare Telos Rx medication options now
Choose LTTL if…
you want compounded full-dose GLP-1 “Compounded By U.S.A. Licensed Pharmacies,” independent lab verification, and an “up to $140 off your first month” promotional offer, and you will confirm eligibility, state availability and renewal terms before enrolling.
Choose Telos Rx if…
you prefer explicit molecule choice with semaglutide available “as low as $99 per month” and tirzepatide “as low as $139 per month,” want the option that a US-licensed provider will decide which molecule fits you, and value the captured statement “Cancel anytime, no penalties.”
Both providers state that compounded medications are not FDA-approved and that treatment is subject to clinician review.